Immuneering Corp · Brief

Next report

124 days

Mar 9 · before openest.Q4 FY26

Expected move

No implied move.

2 reportsHistory

—≥ implied

Q2 FY26±18.2%▼−0.23%×0.01

Oct 29 '26±23.8%▼−6.84%×0.29

quarterimplied−25%0+25%realized×

Oct '26±23.8%▼−6.84%×0.29

Q2 FY26±18.2%▼−0.23%×0.01

Shaded = implied · tick ▲▼ = realized · × = |realized| ÷ impliedSource: options EOD · implied at prior close · realized close to close

Mar 9 report · est.

Bull2 of 3

4supplier and customer relationships disclosed in filingsSEC filings

3tracked funds reporting positions in the companyN-PORT · Aug 31 '26

Bear1

5 of 23largest reporting managers that reduced their stakes in the quarter13F · Jun 30 '26

AI captions · Nov 2 '26once per report · top 2 per case

IMRX report session

No linked exposure.

Oct 29impliedImplied move: ±23.8% into Oct 29 earnings (Oct 29 close).Source

Oct 28impliedImplied move: ±26.1% into Nov 11 earnings (Oct 28 close).Source

privateThesis 0 · Decisions 0 · Observations 0

No thesis.